FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024338659> ?p ?o ?g. }

• W2024338659 endingPage "2326" @default.
• W2024338659 startingPage "2318" @default.
• W2024338659 abstract "Limited proteolysis in vivo of insulin-like growth factor-binding protein-3 (IGFBP-3) by as yet unidentified serine proteases plays a key role in controlling the bioavailability of IGFBP-3-associated insulin-like growth factors (IGFs). Both the IGF system and the system of plasminogen activators (PAs) and their inhibitors (PAIs) are involved in bone remodeling, and plasmin has been shown to provoke dissociation of IGFBP-IGF complexes in cultured MG-63 human osteoblasts. The aim of this work was to investigate interactions between IGF-I and the PA/PAI system and their influence on IGFBP-3 production and proteolysis in this cell model. At confluency, MG-63 cells maintained for 3 days in serum-free medium constitutively secreted IGFBP-2 and small amounts of IGFBP-3 and IGFBP-4. As shown by Western ligand and immunoblot analyses of the culture medium and Northern blot analysis of IGFBP-3 messenger RNA, production of these IGFBPs, and of IGFBP-3 in particular, was dose dependently stimulated by the addition of 12.5-100 ng/ml recombinant human (rh) IGF-I. Increasing concentrations of plasminogen (0.05-3.5 micrograms/ml) added during the final 12 h of culture reduced the amounts of IGFBP detectable by Western ligand blotting, especially IGFBP-3. This reduction reflected proteolysis, as shown by immunoblotting, which revealed 30-, 20-, and 16-kilodalton fragments of IGFBP-3. In the presence of 25 ng/ml IGF-I, which stimulated IGFBP-3 production, proteolysis was reduced by approximately half. Incubation of glycosylated [125I]rh-IGFBP-3 as substrate in cell-free conditioned medium gave the same results. Addition of 50 ng/ml rhIGF-I to conditioned medium (to promote IGFBP-3-rhIGF-I complex formation) failed to diminish plasmin-induced proteolysis of IGFBP-3. Urokinase PA activity in the conditioned medium decreased significantly when the cells were cultured with rhIGF-I, indicating a direct action of IGF-I on urokinase PA and/or PAI production. Our results support the notion of a regulation loop whereby IGF-I controls its own bioavailability via its action on both IGFBP-3 production and the PA/PAI system, which regulates IGFBP-3 proteolysis. The proteolytic cleavages of IGFBP-3 caused by plasmin were the same as those caused in vivo by serine protease acting on this IGFBP." @default.
• W2024338659 created "2016-06-24" @default.
• W2024338659 creator A5014283513 @default.
• W2024338659 creator A5020157707 @default.
• W2024338659 creator A5050518805 @default.
• W2024338659 creator A5077894986 @default.
• W2024338659 creator A5078149259 @default.
• W2024338659 date "1994-12-01" @default.
• W2024338659 modified "2023-10-18" @default.
• W2024338659 title "Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells." @default.
• W2024338659 cites W1605635614 @default.
• W2024338659 cites W1775749144 @default.
• W2024338659 cites W1972819401 @default.
• W2024338659 cites W1974086084 @default.
• W2024338659 cites W1986819031 @default.
• W2024338659 cites W1988992304 @default.
• W2024338659 cites W1989567446 @default.
• W2024338659 cites W1997734995 @default.
• W2024338659 cites W1999920704 @default.
• W2024338659 cites W2002621910 @default.
• W2024338659 cites W2006269656 @default.
• W2024338659 cites W2006393438 @default.
• W2024338659 cites W2007006137 @default.
• W2024338659 cites W2007657701 @default.
• W2024338659 cites W2008112937 @default.
• W2024338659 cites W2013157204 @default.
• W2024338659 cites W2017309664 @default.
• W2024338659 cites W2017530941 @default.
• W2024338659 cites W2023205840 @default.
• W2024338659 cites W2024034633 @default.
• W2024338659 cites W2029950894 @default.
• W2024338659 cites W2034321052 @default.
• W2024338659 cites W2038012173 @default.
• W2024338659 cites W2048627616 @default.
• W2024338659 cites W2051679650 @default.
• W2024338659 cites W2055598444 @default.
• W2024338659 cites W2058389954 @default.
• W2024338659 cites W2064350456 @default.
• W2024338659 cites W2066581502 @default.
• W2024338659 cites W2084537045 @default.
• W2024338659 cites W2090277249 @default.
• W2024338659 cites W2107908226 @default.
• W2024338659 cites W2108604179 @default.
• W2024338659 cites W2122112217 @default.
• W2024338659 cites W2133153888 @default.
• W2024338659 cites W2134311390 @default.
• W2024338659 cites W2140204001 @default.
• W2024338659 cites W2150197145 @default.
• W2024338659 cites W2150472477 @default.
• W2024338659 cites W2152672354 @default.
• W2024338659 cites W2156629482 @default.
• W2024338659 cites W2395789608 @default.
• W2024338659 cites W2408595112 @default.
• W2024338659 cites W2412790711 @default.
• W2024338659 cites W2414133988 @default.
• W2024338659 doi "https://doi.org/10.1210/endo.135.6.7527330" @default.
• W2024338659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7527330" @default.
• W2024338659 hasPublicationYear "1994" @default.
• W2024338659 type Work @default.
• W2024338659 sameAs 2024338659 @default.
• W2024338659 citedByCount "61" @default.
• W2024338659 countsByYear W20243386592013 @default.
• W2024338659 countsByYear W20243386592018 @default.
• W2024338659 countsByYear W20243386592020 @default.
• W2024338659 countsByYear W20243386592021 @default.
• W2024338659 crossrefType "journal-article" @default.
• W2024338659 hasAuthorship W2024338659A5014283513 @default.
• W2024338659 hasAuthorship W2024338659A5020157707 @default.
• W2024338659 hasAuthorship W2024338659A5050518805 @default.
• W2024338659 hasAuthorship W2024338659A5077894986 @default.
• W2024338659 hasAuthorship W2024338659A5078149259 @default.
• W2024338659 hasConcept C104317684 @default.
• W2024338659 hasConcept C126322002 @default.
• W2024338659 hasConcept C134018914 @default.
• W2024338659 hasConcept C153911025 @default.
• W2024338659 hasConcept C170493617 @default.
• W2024338659 hasConcept C181199279 @default.
• W2024338659 hasConcept C182220744 @default.
• W2024338659 hasConcept C185592680 @default.
• W2024338659 hasConcept C2775960820 @default.
• W2024338659 hasConcept C2780378035 @default.
• W2024338659 hasConcept C2780689927 @default.
• W2024338659 hasConcept C2781071845 @default.
• W2024338659 hasConcept C2781307694 @default.
• W2024338659 hasConcept C55493867 @default.
• W2024338659 hasConcept C71924100 @default.
• W2024338659 hasConcept C85265743 @default.
• W2024338659 hasConcept C86803240 @default.
• W2024338659 hasConceptScore W2024338659C104317684 @default.
• W2024338659 hasConceptScore W2024338659C126322002 @default.
• W2024338659 hasConceptScore W2024338659C134018914 @default.
• W2024338659 hasConceptScore W2024338659C153911025 @default.
• W2024338659 hasConceptScore W2024338659C170493617 @default.
• W2024338659 hasConceptScore W2024338659C181199279 @default.
• W2024338659 hasConceptScore W2024338659C182220744 @default.
• W2024338659 hasConceptScore W2024338659C185592680 @default.
• W2024338659 hasConceptScore W2024338659C2775960820 @default.
• W2024338659 hasConceptScore W2024338659C2780378035 @default.

• next